Impaired lymphocyte function in patients with hepatic malignancies after selective internal radiotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Impaired lymphocyte function in patients with hepatic malignancies after selective internal radiotherapy

Published:2018-03-02 Issue:5 Volume:67 Page:843-853
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Domouchtsidou Aglaia,Barsegian Vahé,Mueller Stefan P.,Best Jan,Ertle Judith,Bedreli Sotiria,Horn Peter A.,Bockisch Andreas,Lindemann Monika

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/article/10.1007/s00262-018-2141-0/fulltext.html

Reference36 articles.

1. Lewandowski RJ, Salem R (2006) Yttrium-90 radioembolization of hepatocellular carcinoma and metastatic disease to the liver. Semin Interv Radiol 23:64–72. https://doi.org/10.1055/s-2006-939842

2. Wang LM, Jani AR, Hill EJ, Sharma RA (2013) Anatomical basis and histopathological changes resulting from selective internal radiotherapy for liver metastases. J Clin Pathol. 66:205–211. https://doi.org/10.1136/jclinpath-2012-201231

3. Breedis C, Young G (1954) The blood supply of neoplasms in the liver. Am J Pathol. 30:969–985

4. Barsegian V, Müller SP, Horn PA, Bockisch A, Lindemann M (2011) Lymphocyte function following radioiodine therapy in patients with thyroid carcinoma. Nuklearmedizin 50:195–203. https://doi.org/10.3413/nukmed-04241108

5. Barsegian V, Hueben C, Mueller SP, Poeppel TD, Horn PA, Bockisch A, Lindemann M (2015) Impairment of lymphocyte function following yttrium-90 DOTATOC therapy. Cancer Immunol Immunother. 64:755–764. https://doi.org/10.1007/s00262-015-1687-3

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing Radioembolization Through Personalized Dosimetry;Advances in Clinical Radiology;2024-09

2. Lymphocyte Function at Baseline Could Be a New Predictor of Tumor Burden following Six Cycles of Radium-223 Therapy in Patients with Metastasized, Castration-Resistant Prostate Cancer;Cancers;2024-02-22

3. Combination Therapy of Immune Checkpoint Inhibitors with Locoregional Therapy for Hepatocellular Carcinoma;Cancers;2023-10-20

4. Minimal Residual Disease Detection at RNA and Leukemic Stem Cell (LSC) Levels: Comparison of RT-qPCR, d-PCR and CD26+ Stem Cell Measurements in Chronic Myeloid Leukemia (CML) Patients in Deep Molecular Response (DMR);Cancers;2023-08-15

5. In Patients Treated by Selective Internal Radiotherapy, Cellular In Vitro Immune Function Is Predictive of Survival;Cancers;2023-08-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3